Loading…
Phage Therapy as a Focused Management Strategy in Aquaculture
Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune res...
Saved in:
Published in: | International journal of molecular sciences 2021-09, Vol.22 (19), p.10436 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3 |
---|---|
cites | cdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3 |
container_end_page | |
container_issue | 19 |
container_start_page | 10436 |
container_title | International journal of molecular sciences |
container_volume | 22 |
creator | Ramos-Vivas, José Superio, Joshua Galindo-Villegas, Jorge Acosta, Félix |
description | Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the
and
, and the
, respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases. |
doi_str_mv | 10.3390/ijms221910436 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2581021043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</originalsourceid><addsrcrecordid>eNpdkc1LAzEQxYMotlaPXmXBi5fVfG_2oFCKVaGiYD2HbDbbbtmPNtkI_e9NbS3W0wwzPx7z5gFwieAtISm8Kxe1wxilCFLCj0AfUYxjCHly_KfvgTPnFhBigll6CnqEciKShPfB_ftczUw0nRurlutIuUhF41Z7Z_LoVTVhV5umiz46qzozW0dlEw1XXmlfdd6ac3BSqMqZi10dgM_x43T0HE_enl5Gw0msKWJdzJM8y2FakNyoFNOsQKnhSCOjcs2poSyDmjGic0pUmAlRpJQlHCEkFEuzggzAw1Z36bPa5DqcZFUll7aslV3LVpXycNOUczlrv6RgUHBBgsDNTsC2K29cJ-vSaVNVqjGtdxIzgQQWCIqAXv9DF623TbD3Q0G8-XSg4i2lbeucNcX-GATlJhh5EEzgr_462NO_SZBvUOeJmg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2581021043</pqid></control><display><type>article</type><title>Phage Therapy as a Focused Management Strategy in Aquaculture</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Ramos-Vivas, José ; Superio, Joshua ; Galindo-Villegas, Jorge ; Acosta, Félix</creator><creatorcontrib>Ramos-Vivas, José ; Superio, Joshua ; Galindo-Villegas, Jorge ; Acosta, Félix</creatorcontrib><description>Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the
and
, and the
, respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms221910436</identifier><identifier>PMID: 34638776</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animals ; Antibiotics ; Aquaculture ; Bacteria ; Bacterial infections ; Bacterial Infections - therapy ; Bacterial Infections - virology ; Biofilms ; Cell division ; Enzymes ; Fish culture ; Genes ; Genomes ; Gram-negative bacteria ; Gram-positive bacteria ; Humans ; Immune clearance ; Immune response ; Immune system ; Immunogenicity ; Immunomodulation ; Livestock ; Lytic enzymes ; Medical research ; Myoviridae ; Pathogens ; Phage Therapy ; Phages ; Podoviridae ; Proteins ; Review ; Siphoviridae ; Viruses</subject><ispartof>International journal of molecular sciences, 2021-09, Vol.22 (19), p.10436</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</citedby><cites>FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</cites><orcidid>0000-0002-4250-2477 ; 0000-0002-1098-7529 ; 0000-0002-8509-2463</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2581021043/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2581021043?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34638776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramos-Vivas, José</creatorcontrib><creatorcontrib>Superio, Joshua</creatorcontrib><creatorcontrib>Galindo-Villegas, Jorge</creatorcontrib><creatorcontrib>Acosta, Félix</creatorcontrib><title>Phage Therapy as a Focused Management Strategy in Aquaculture</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the
and
, and the
, respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>Aquaculture</subject><subject>Bacteria</subject><subject>Bacterial infections</subject><subject>Bacterial Infections - therapy</subject><subject>Bacterial Infections - virology</subject><subject>Biofilms</subject><subject>Cell division</subject><subject>Enzymes</subject><subject>Fish culture</subject><subject>Genes</subject><subject>Genomes</subject><subject>Gram-negative bacteria</subject><subject>Gram-positive bacteria</subject><subject>Humans</subject><subject>Immune clearance</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunogenicity</subject><subject>Immunomodulation</subject><subject>Livestock</subject><subject>Lytic enzymes</subject><subject>Medical research</subject><subject>Myoviridae</subject><subject>Pathogens</subject><subject>Phage Therapy</subject><subject>Phages</subject><subject>Podoviridae</subject><subject>Proteins</subject><subject>Review</subject><subject>Siphoviridae</subject><subject>Viruses</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1LAzEQxYMotlaPXmXBi5fVfG_2oFCKVaGiYD2HbDbbbtmPNtkI_e9NbS3W0wwzPx7z5gFwieAtISm8Kxe1wxilCFLCj0AfUYxjCHly_KfvgTPnFhBigll6CnqEciKShPfB_ftczUw0nRurlutIuUhF41Z7Z_LoVTVhV5umiz46qzozW0dlEw1XXmlfdd6ac3BSqMqZi10dgM_x43T0HE_enl5Gw0msKWJdzJM8y2FakNyoFNOsQKnhSCOjcs2poSyDmjGic0pUmAlRpJQlHCEkFEuzggzAw1Z36bPa5DqcZFUll7aslV3LVpXycNOUczlrv6RgUHBBgsDNTsC2K29cJ-vSaVNVqjGtdxIzgQQWCIqAXv9DF623TbD3Q0G8-XSg4i2lbeucNcX-GATlJhh5EEzgr_462NO_SZBvUOeJmg</recordid><startdate>20210928</startdate><enddate>20210928</enddate><creator>Ramos-Vivas, José</creator><creator>Superio, Joshua</creator><creator>Galindo-Villegas, Jorge</creator><creator>Acosta, Félix</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4250-2477</orcidid><orcidid>https://orcid.org/0000-0002-1098-7529</orcidid><orcidid>https://orcid.org/0000-0002-8509-2463</orcidid></search><sort><creationdate>20210928</creationdate><title>Phage Therapy as a Focused Management Strategy in Aquaculture</title><author>Ramos-Vivas, José ; Superio, Joshua ; Galindo-Villegas, Jorge ; Acosta, Félix</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>Aquaculture</topic><topic>Bacteria</topic><topic>Bacterial infections</topic><topic>Bacterial Infections - therapy</topic><topic>Bacterial Infections - virology</topic><topic>Biofilms</topic><topic>Cell division</topic><topic>Enzymes</topic><topic>Fish culture</topic><topic>Genes</topic><topic>Genomes</topic><topic>Gram-negative bacteria</topic><topic>Gram-positive bacteria</topic><topic>Humans</topic><topic>Immune clearance</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunogenicity</topic><topic>Immunomodulation</topic><topic>Livestock</topic><topic>Lytic enzymes</topic><topic>Medical research</topic><topic>Myoviridae</topic><topic>Pathogens</topic><topic>Phage Therapy</topic><topic>Phages</topic><topic>Podoviridae</topic><topic>Proteins</topic><topic>Review</topic><topic>Siphoviridae</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramos-Vivas, José</creatorcontrib><creatorcontrib>Superio, Joshua</creatorcontrib><creatorcontrib>Galindo-Villegas, Jorge</creatorcontrib><creatorcontrib>Acosta, Félix</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Hospital Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Research Library</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Health & Medical Collection</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramos-Vivas, José</au><au>Superio, Joshua</au><au>Galindo-Villegas, Jorge</au><au>Acosta, Félix</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phage Therapy as a Focused Management Strategy in Aquaculture</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-09-28</date><risdate>2021</risdate><volume>22</volume><issue>19</issue><spage>10436</spage><pages>10436-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Therapeutic bacteriophages, commonly called as phages, are a promising potential alternative to antibiotics in the management of bacterial infections of a wide range of organisms including cultured fish. Their natural immunogenicity often induces the modulation of a variated collection of immune responses within several types of immunocytes while promoting specific mechanisms of bacterial clearance. However, to achieve standardized treatments at the practical level and avoid possible side effects in cultivated fish, several improvements in the understanding of their biology and the associated genomes are required. Interestingly, a particular feature with therapeutic potential among all phages is the production of lytic enzymes. The use of such enzymes against human and livestock pathogens has already provided in vitro and in vivo promissory results. So far, the best-understood phages utilized to fight against either Gram-negative or Gram-positive bacterial species in fish culture are mainly restricted to the
and
, and the
, respectively. However, the current functional use of phages against bacterial pathogens of cultured fish is still in its infancy. Based on the available data, in this review, we summarize the current knowledge about phage, identify gaps, and provide insights into the possible bacterial control strategies they might represent for managing aquaculture-related bacterial diseases.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34638776</pmid><doi>10.3390/ijms221910436</doi><orcidid>https://orcid.org/0000-0002-4250-2477</orcidid><orcidid>https://orcid.org/0000-0002-1098-7529</orcidid><orcidid>https://orcid.org/0000-0002-8509-2463</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2021-09, Vol.22 (19), p.10436 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508683 |
source | Publicly Available Content Database; PubMed Central |
subjects | Animals Antibiotics Aquaculture Bacteria Bacterial infections Bacterial Infections - therapy Bacterial Infections - virology Biofilms Cell division Enzymes Fish culture Genes Genomes Gram-negative bacteria Gram-positive bacteria Humans Immune clearance Immune response Immune system Immunogenicity Immunomodulation Livestock Lytic enzymes Medical research Myoviridae Pathogens Phage Therapy Phages Podoviridae Proteins Review Siphoviridae Viruses |
title | Phage Therapy as a Focused Management Strategy in Aquaculture |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-06T15%3A24%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phage%20Therapy%20as%20a%20Focused%20Management%20Strategy%20in%20Aquaculture&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Ramos-Vivas,%20Jos%C3%A9&rft.date=2021-09-28&rft.volume=22&rft.issue=19&rft.spage=10436&rft.pages=10436-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms221910436&rft_dat=%3Cproquest_pubme%3E2581021043%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-67dbd09f3dea924bf19e61c1eadc64e45b0c553cd43aead88f945761118a59bf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2581021043&rft_id=info:pmid/34638776&rfr_iscdi=true |